SCHEMBL250561

SCHEMBL250561

CN(C)C1(c2cccs2)CCC(N)CC1.O=C(O)CCCC(=O)NCCc1ccc(Br)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
NCOR2 Q9Y618 2/20 0.39
HDAC4 P56524 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
NOS1 P29475 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
OPRM1 P35372 2/20 0.37
OPRL1 P41146 2/20 0.37
POLB P06746 1/20 0.37
CTDSP1 Q9GZU7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL250442 0.86 MEN1 (0.42) LMNATSHRMEN1KMT2A
SCHEMBL207653 0.86 OPRM1 (0.43) SMN1; SMN2OPRM1OPRL1POLBCTDSP1
SCHEMBL249994 0.84 NPC1 (0.45) LMNASMN1; SMN2MEN1KMT2AOPRM1
SCHEMBL251293 0.81 ENPP2 (0.42) SMN1; SMN2POLB
SCHEMBL249977 0.79 SMN1; SMN2 (0.46) SMN1; SMN2KMT2A
SCHEMBL251283 0.78 OPRM1 (0.44) OPRM1OPRL1
SCHEMBL4074080 0.77 OPRM1 (0.51) OPRM1OPRL1
SCHEMBL250033 0.77 OPRL1 (0.42) OPRM1OPRL1
SCHEMBL248430 0.77 THRB (0.37) LMNATSHRSMN1; SMN2MEN1KMT2A
SCHEMBL248648 0.77 NPC1 (0.38) LMNASMN1; SMN2KMT2AOPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed